Abstract
Chiharu Ueda, Tamaki Tokumatsu, Fuka Sogame, Nobuaki Chiba, Toshio Norikura, Yutaro Sasaki, Isao Matsui-Yuasa, Akiko Kojima-Yuasa
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Parkinson’s disease
10.1016/s0140-6736(14)61393-3 · 2015
The prevalence of parkinson’s disease: a systematic review and meta-analyis
10.1002/mds.25945 · 2014
The Parkinson pandemic-a call to action
10.1001/jamaneurol.2017.3299 · 2018
Progression of moter symptoms in Parkinson’s disease
10.1007/s12264-012-1050-z · 2012
Oxidative stress and regulated cell death in Parkinson’s disease
10.1016/j.arr.2021.101263 · 2021
Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions
10.1038/s41392-023-01353-3 · 2023
Oxidative stress, mitochondria dysfunction and neurodegenerative disease; a mechanistic insight
10.1016/j.biopha.2015.07.025 · 2015
Oxidative stress sensor keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2
10.1128/mcb.24.16.7130-7139.2004 · 2004
Direct evidence that sulfhydryl groups of Keaor1 are sensor regulating induction of phase 2 enzymes that protect against and carcinogens oxidants
10.1073/pnas.172398899 · 2002
Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain
10.1101/gad.13.1.76 · 1999
62-Nrf2-p62 mitophagy regulatory loop as a target for preventive therapy of neurodegenerative diseases
10.3390/brainsci10110847 · 2020
p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription
10.1074/jbc.m110.118976 · 2010
Rotenone-induced model of Parkinson’s disease: beyond mitochondrial complex I inhibition
10.1007/s12035-022-03193-8 · 2023
Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production
10.1074/jbc.m210432200 · 2003
Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection
10.4061/2011/617472 · 2010
Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone
10.1111/j.1471-4159.2006.04440.x · 2007
Gut–brain and brain–gut axis in Parkinson’s disease models: Effects of a uridine and fish oil diet
10.1080/1028415x.2017.1294555 · 2018
A flavonoid-rich extract of mandarin juice counteracts 6-OHDA-induced oxidative stress in SH-SY5Y cells and modulates Parkinson-related genes
10.3390/antiox10040539 · 2021
Strawberry Fragaria x ananssa cv. Festival: a polyphenol-based phytochemical characterization in fruit and leaf extracts
10.3390/molecules28041865 · 2023
Non-targeted metabolite profiling highlights the potential of strawberry leaves as a resource for specific bioactive compounds
10.1002/jsfa.8027 · 2017
Antioxidant activity in fruits and leaves of blackberry, raspberry, and strawberry varies with cultivar and developmental stage
10.1021/jf9908345 · 2000
Strawberry leaf extract treatment alleviates cognitive impairment by activating Nrf2/HO-1 signaling in rats with streptozotocin-induced diabetes
10.3389/fnagi.2020.00201 · 2020
Maximizing the recovery of phenolic antioxidants from wild strawberry (Fragaria vesca) leaves using microwave-assisted extraction and accelerated solvent extraction
10.3390/pr11123378 · 2023
Ecklonia cava polyphenols have a preventive effect on Parkinson’ s disease through the activation of the Nrf2-ARE pathway
10.3390/nu16132076 · 2024
Pharmacological modulation of Nrf2/HO-1 signaling pathway as a therapeutic target of Parkinson’s disease
10.3389/fphar.2021.757161 · 2021
Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival
10.1152/ajpheart.00749.2010 · 2010
Chronic systemic pesticide exposure reproduces features of Parkinson’s disease
10.1038/81834 · 2000
Mechanism of toxicity in rotenone models of Parkinson’s disease
10.1523/jneurosci.23-34-10756.2003 · 2007
The role of oxidative stress in Parkinson’s disease
10.3233/jpd-130230 · 2013
Slowing of neurodegeneration in Parkinson’s disease and Huntington’s disease: future therapeutic perspectives
10.1016/s0140-6736(14)61010-2 · 2014
Role of Nrf2 in oxidative stress and toxicity
10.1146/annurev-pharmtox-011112-140320 · 2013
Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathways
10.1146/annurev.pharmtox.46.120604.141046 · 2007
The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1
10.1038/ncb2021 · 2010
AMPK facilitates nuclear accumulation of Nrf2 by phosphorylating at serine 550
10.1128/mcb.00118-16 · 2016
AMPK leaalian ds to phosphorylation of transcription factor Nrf2, tuning transactivation of selected target genes
10.1016/j.redox.2019.101393 · 2020
The role of PINK1, Parkin, and mitochondrial fidelity in Parkinson’s disease
10.1016/j.neuron.2014.12.007 · 2015
Autophagy in mammalian development and differentiation
10.1038/ncb0910-823 · 2010
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
10.1083/jcb.200809125 · 2008
The role of mitochondria in apoptosis
10.1146/annurev-genet-102108-134850 · 2009
A highly reproducible rotenone model of Parkinson’s disease
10.1016/j.nbd.2009.01.016 · 2009
Flavonoids: antioxidants or signalling molecules?
10.1016/j.freeradbiomed.2004.01.001 · doi-reference
Dietary polyphenols and the prevention of diseases
10.1080/1040869059096 · doi-reference
Flavonoid permeability across an in situ model of the blood-brain barrier
10.1016/j.freeradbiomed.2003.11.023 · doi-reference
Flvonoids: modulators of brain function?
10.1017/s0007114508965776 · doi-reference
An update on the rotenone models of Parkinson’s disease: their ability to reproduce the features of clinical disease and model gene-environment interactions
10.1016/j.neuro.2014.12.002 · doi-reference